Assessment of Antimicrobial Agents, Analgesics, and Epidermal Growth Factors-Embedded Anti-Adhesive Poly(Lactic-Co-Glycolic Acid) Nanofibrous Membranes: In vitro and in vivo Studies

Abstract

Background Postoperative tissue adhesion is a major concern for most surgeons and is a nearly unpreventable complication after abdominal or pelvic surgeries. This study explored the use of sandwich-structured antimicrobial agents, analgesics, and human epidermal growth factor (hEGF)-incorporated anti-adhesive poly(lactic-co-glycolic acid) nanofibrous membranes for surgical wounds. Materials and Methods Electrospinning and co-axial electrospinning techniques were utilized in fabricating the membranes. After spinning, the properties of the prepared membranes were assessed. Additionally, high-performance liquid chromatography and enzyme-linked immunosorbent assays were utilized in assessing the in vitro and in vivo liberation profiles of the pharmaceuticals and the hEGF from the membranes. Results The measured data suggest that the degradable anti-adhesive membranes discharged high levels of vancomycin/ceftazidime, ketorolac, and hEGF in vitro for more than 30, 24, and 27 days, respectively. The in vivo assessment in a rat laparotomy model indicated no adhesion in the peritoneal cavity at 14 days post-operation, demonstrating the anti-adhesive capability of the sandwich-structured nanofibrous membranes. The nanofibers also released effective levels of vancomycin, ceftazidime, and ketorolac for more than 28 days in vivo. Histological examination revealed no adverse effects. Conclusion The outcomes of this study implied that the anti-adhesive nanofibers with sustained release of antimicrobial agents, analgesics, and growth factors might offer postoperative pain relief and infection control, as well as promote postoperative healing of surgical wounds.

Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis

“…Several factors may affect the release of pharmaceuticals from PLGA matrix systems [ 47 ], including the molecular weight and hydrophilicity of incorporated drugs, the rate of aqueous medium infiltration into the matrix, and the rate of matrix erosion. In general, the release curves can be partitioned into three stages: a primary blast, diffusion-governed discharge, and degradation-controlled release [ 48 ]. After the spinning procedure, most drugs are distributed in the nanofiber volume.…”

Novel Biodegradable 3D-Printed Analgesics-Eluting-Nanofibers Incorporated Nuss Bars for Therapy of Pectus Excavatum

“…Among distinct biomaterials, PLGA has demonstrated itself great potential as a drug delivery carrier and as scaffolds for tissue engineering [8,18]. The degradation rate of PLGA is related to the LA:GA monomers' ratio, and the copolymer with 50:50 ratio exhibits the faster degradation (approximately 1-2 months) [19][20][21]. Our previous study incorporated analgesic-eluting nanofibers onto metallic Nuss bar and achieved the sustained and effective release of lidocaine and ketorolac for post-surgery pain relief for over 10 days (28.3 µg/mL and 17.8 µg/mL, respectively, for lidocaine and ketorolac at day 10) [22].…”

Simvastatin-Loaded Nanofibrous Membrane Efficiency on the Repair of Achilles Tendons

“…After surgery, each rat was maintained in an activity behavior cage 29 to observe the degree of postoperative activity. The cage was equipped with nine photoelectric sensors on top of nine symmetric square regions.…”